** Aveanna Healthcare Holdings' AVAH.O shares rise 17.1% to $4.38 during pre-market trading
** Atlanta-based company expects FY25 rev to be between $2.10 - $2.12 billion, mid-point of which is in line with analysts' estimates of $2.11 billion - LSEG
** Co posts Q4 revenue of $519.9 million, beating analyst estimates of $499.6 million
** "We expect continued organic volume growth, improved clinical outcomes, and enhanced profitability into 2025" - CFO Matt Buckhalter
** Including session's gain, co's shares down about 18% YTD
(Reporting by Bageshri Banerjee)
((bageshri.banerjee@thomsonreuters.com; Ph: 7003700554))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。